Literature DB >> 8495121

Cardiovascular risk factors in perspective.

S G Carruthers1.   

Abstract

Coronary heart disease and other manifestations of atherosclerosis are leading causes of morbidity and mortality in Canada. Despite favourable trends in recent years, we should try to reduce cardiovascular events further. Physicians must translate current knowledge into public health policies and management strategems for individual patients. Patients are best served by a comprehensive risk management approach, involving nonpharmacological (mainly lifestyle) changes and drug therapy.

Entities:  

Mesh：

Year:  1993        PMID： 8495121      PMCID： PMC2379737     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


  20 in total

1.  Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study.

Authors:  P A Sytkowski; W B Kannel; R B D'Agostino
Journal:  N Engl J Med       Date:  1990-06-07       Impact factor: 91.245

2.  The Medical Research Council Hypertension Trial: the smoking patient.

Authors:  C Dollery; P J Brennan
Journal:  Am Heart J       Date:  1988-01       Impact factor: 4.749

3.  Body weight and longevity. A reassessment.

Authors:  J E Manson; M J Stampfer; C H Hennekens; W C Willett
Journal:  JAMA       Date:  1987-01-16       Impact factor: 56.272

4.  Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial.

Authors:  W B Kannel; J D Neaton; D Wentworth; H E Thomas; J Stamler; S B Hulley; M O Kjelsberg
Journal:  Am Heart J       Date:  1986-10       Impact factor: 4.749

5.  The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh Blood Pressure study.

Authors:  S Julius; K Jamerson; A Mejia; L Krause; N Schork; K Jones
Journal:  JAMA       Date:  1990-07-18       Impact factor: 56.272

6.  Decline in the risk of myocardial infarction among women who stop smoking.

Authors:  L Rosenberg; J R Palmer; S Shapiro
Journal:  N Engl J Med       Date:  1990-01-25       Impact factor: 91.245

7.  Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial.

Authors:  L Wilhelmsen; G Berglund; D Elmfeldt; T Fitzsimons; H Holzgreve; J Hosie; P E Hörnkvist; K Pennert; J Tuomilehto; H Wedel
Journal:  J Hypertens       Date:  1987-10       Impact factor: 4.844

8.  Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60.

Authors:  A Amery; W Birkenhäger; R Brixko; C Bulpitt; D Clement; M Deruyttere; A De Schaepdryver; C Dollery; R Fagard; F Forette
Journal:  Lancet       Date:  1986-09-13       Impact factor: 79.321

Review 9.  Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.

Authors:  R Collins; R Peto; S MacMahon; P Hebert; N H Fiebach; K A Eberlein; J Godwin; N Qizilbash; J O Taylor; C H Hennekens
Journal:  Lancet       Date:  1990-04-07       Impact factor: 79.321

10.  Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias.

Authors:  S MacMahon; R Peto; J Cutler; R Collins; P Sorlie; J Neaton; R Abbott; J Godwin; A Dyer; J Stamler
Journal:  Lancet       Date:  1990-03-31       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.